Interpace Biosciences, Inc. (IDXG)
6.025
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
Interpace Biosciences Free Cash Flow : 4.104M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.104M |
| March 31, 2026 | 4.382M |
| December 31, 2025 | 5.475M |
| September 30, 2025 | 4.43M |
| June 30, 2025 | 4.203M |
| March 31, 2025 | 5.091M |
| December 31, 2024 | 3.77M |
| September 30, 2024 | 3.713M |
| June 30, 2024 | 3.072M |
| March 31, 2024 | 2.165M |
| December 31, 2023 | 3.319M |
| September 30, 2023 | 1.849M |
| June 30, 2023 | -2.388M |
| March 31, 2023 | -5.673M |
| December 31, 2022 | -8.014M |
| September 30, 2022 | -8.922M |
| June 30, 2022 | -6.476M |
| March 31, 2022 | -5.463M |
| December 31, 2021 | -9.196M |
| September 30, 2021 | -9.70M |
| June 30, 2021 | -14.95M |
| March 31, 2021 | -13.44M |
| December 31, 2020 | -15.55M |
| September 30, 2020 | -20.10M |
| June 30, 2020 | -18.84M |
| Date | Value |
|---|---|
| March 31, 2020 | -23.24M |
| December 31, 2019 | -19.09M |
| September 30, 2019 | -14.60M |
| June 30, 2019 | -11.85M |
| March 31, 2019 | -9.54M |
| December 31, 2018 | -9.122M |
| September 30, 2018 | -9.567M |
| June 30, 2018 | -11.72M |
| March 31, 2018 | -13.70M |
| December 31, 2017 | -15.29M |
| September 30, 2017 | -13.90M |
| June 30, 2017 | -11.01M |
| March 31, 2017 | -7.786M |
| December 31, 2016 | -7.607M |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| September 30, 2015 | -24.08M |
| June 30, 2015 | -18.76M |
| March 31, 2015 | -18.33M |
| December 31, 2014 | -19.23M |
| September 30, 2014 | -13.18M |
| June 30, 2014 | -12.95M |
| March 31, 2014 | -13.08M |
| December 31, 2013 | -5.33M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| PD-Rx Pharmaceuticals, Inc. | -- |
| Medical Marijuana, Inc. | -0.3957M |
| Acro Biomedical Co. Ltd. | -0.1401M |
| Stella Diagnostics, Inc. | -2.365M |
| ZeroStack Corp. | -5.478M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 0.098M |
| Cash from Investing (Quarterly) | -0.057M |
| Free Cash Flow Per Share (Quarterly) | 0.0074 |
| Free Cash Flow to Equity (Quarterly) | 0.147M |
| Free Cash Flow to Firm (Quarterly) | 0.041M |
| Free Cash Flow Yield | 12.29% |